Abbvie Inc
Change company Symbol lookup
Select an option...
ABBV Abbvie Inc
OII Oceaneering International Inc
ACQRU Independence Holdings Corp
IFPJF Informa PLC
FKWL Franklin Wireless Corp
VTI.IV Vanguard Total Stock Market ETF
$NQUSL40501010AUDT Nasdaq US Large Cap Airlines Total R
VLO Valero Energy Corp
OKE ONEOK Inc
MMS Maximus Inc
Go

Health Care : Biotechnology | Large Cap Value
Company profile

AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. AbbVie offers its products in various therapeutic categories, including Immunology products, which include Humira, Skyrizi and Rinvoq; Oncology products consists of Imbruvica and Venclexta; Aesthetics products include Botox Cosmetic, Juvederm Collection and other aesthetics; Neuroscience products, such as Botox Therapeutic, Vraylar, Duopa and Duodopa, and Ubrelvy; Eye care products consists of Lumigan, Alphagan and Restasis ; Women's health products incudes Lo Loestrin, Orilissa and other women's health; and Other key products, which includes Mavyret, Creon, Lupron, Linzess and Synthroid. The Company's products are sold worldwide directly to wholesalers, distributors, government agencies, health care facilities and independent retailers from AbbVie-owned distribution centers and public warehouses.

Closing Price
$107.73
Day's Change
-0.35 (-0.32%)
Bid
--
Ask
--
B/A Size
--
Day's High
108.25
Day's Low
107.10
Volume
(Heavy Day)
Volume:
14,165,421

10-day average volume:
9,318,383
14,165,421

Alzheimer's Drugs Market Report 2021-2028 | Size, Share, Growth, Trends, Competitive Landscape, Revenue, Forecast Report

4:33 am ET July 14, 2021 (Globe Newswire) Print

Increasing prevalence of Alzheimer's disease is fueling the demand for Alzheimer's drugs which in turn is driving the global Alzheimer's drugs market, says Fortune Business Insights in a report, titled "Alzheimer's Drugs Market", Size, Share and Global Trend By Drug Class (Cholinesterase Inhibitors, N-Methyl-D-Aspartate (NMDA) Antagonist, Combination Drugs, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and Geography Forecast till 2026.

Rising R&D activities by pharmaceutical companies and research institutes for Alzheimer effective therapy is expected to boost the global Alzheimer's drugs market.

Request a Sample Copy of the Research Report:

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/alzheimers-drugs-market-101033

The report covers:

Increasing R&D Investments by Pharmaceutical Companies Will Propel Growth

The active study of Alzheimer's drug by pharmaceutical industries and research institutes for creating a strong pipeline for effective therapy is predicted to encourage growth of the global Alzheimer's drugs market. According to the World Health Organization (WHO) currently, 50 million people are affected by dementia, and the number is expected to increase during the forecast period. In addition, the increasing cases of Alzheimer's disease around the world have led towards high demand for Alzheimer's drugs, which in turn is boosting the global Alzheimer's drugs growth.

The Collaboration Between Eli Lilly and AC Immune Will Aid Growth

Eli Lilly and Company and AC Immune SA announced their partnership agreement to research and develop tau aggregation inhibitor small molecules for the potential treatment of Alzheimer's disease (AD) and other neurodegenerative diseases. The collaboration between the two companies is predicted to benefit Alzheimer's drugs revenue owing to the Morphomer(TM) platform technology which will offer commercial capabilities in central nervous system disorders along with AC Immune's lead molecule, ACI-3024. Furthermore, the development of digital tools for Alzheimer's disease and dementia is also expected to contribute to the global Alzheimer's drugs growth. For instance, the Alzheimer's Drug Discovery Foundation (ADDF), announced a new initiative -Diagnostics Accelerator program that aims to track the development of digital tools for Alzheimer's disease and dementia.

For more information in the analysis of this report, visit:

https://www.fortunebusinessinsights.com/industry-reports/alzheimers-drugs-market-101033

Leading Players operating in the Alzheimer's Drugs Market are:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

Have Any Query? Ask Our Experts:

https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/alzheimers-drugs-market-101033

Increasing Prevalence of Alzheimer's Disease Will Boost Growth in North America

Geographically, the global Alzheimer's drugs market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The global Alzheimer's drugs market is predicted to expand in North America during the forecast period owing to the rising cases of Alzheimer's disease and the presence of key players in the region. According to Alzheimer's Association, currently, 5.8 million Americans are living with Alzheimer's, and the number is expected to increase to 14 million by 2050, which is expected to promote the growth of the Alzheimer's drugs market in North America.

Europe is predicted to grow significantly during the forecast period owing to the increasing prevalence of Alzheimer's disease. Improving diagnostic capabilities are also expected to boost the market in the region. Evolving healthcare infrastructure and rising awareness regarding Alzheimer's disease are expected to contribute significantly to Alzheimer's drugs growth in Asia Pacific and Latin America. Additionally, Alzheimer's drugs market in Middle East & Africa is in the nascent stage; however, unmet needs for Alzheimer's disease is expected to drive the Alzheimer's drugs market in this region.

Global Alzheimer's Drugs Market Segmentation

By Drug Class

By Distribution Channel

By Application

Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/alzheimers-drugs-market-101033

SECONDARY RESEARCH IS CONDUCTED TO DERIVE THE FOLLOWING INFORMATION:

-- Details such as revenues, market share, strategies, growth rate, product & their pricing by region/country for all major companies

-- Details in relation to prevalence, incidence, patient numbers, distribution of patients, average price of treatment, etc.

-- Number of end user facilities by region/country and average annual spending or procurement of devices by type of end user facility

-- Number of procedures and average price of procedures

-- Replacement rate and pricing of capital equipment

-- Market dynamics in relation to the market under focus - Drivers, restraints, trends, and opportunities

-- Market & technological trends, new product developments, product pipeline.

About Us:

Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights(TM) we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights(TM) Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune - 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Fortune Business Insights(TM)

LinkedIn | Twitter | Blogs

https://ml.globenewswire.com/media/05408ba1-26b1-4fdd-8f48-1af4df373348/small/fbi-logo-tm-png.png

https://ml.globenewswire.com/media/05408ba1-26b1-4fdd-8f48-1af4df373348/small/fbi-logo-tm-png.png

comtex tracking

COMTEX_389779604/2010/2021-07-14T04:33:02

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.